| % of Total Score per Kidney | |||
---|---|---|---|---|
Tsc2+/-Cohort (strain, treatment, age) | Cyst | Pre-papillary | Papillary | Solid |
C57BL/6, untreated, 9 months | 13.34 | 26.67 | 45.88 | 14.11 |
C57BL/6, untreated, 12 months | 8.64 | 34.15 | 43.21 | 8.64 |
A/J, untreated, 3 months | 11.54 | 19.23 | 57.69 | 11.54 |
A/J, untreated, 5 months | 9.47 | 21.59 | 62.12 | 6.82 |
A/J, untreated, 7 months | 4.98 | 23.6 | 60.17 | 11.26 |
A/J, untreated, 9 months | 12.38 | 21.27 | 53.63 | 12.51 |
A/J, untreated, 12 months | 11.18 | 16.75 | 59.07 | 13.52 |
Group 1 A/J rapa daily × 4 weeks then weekly × 8 weeks | 31.4 | 51.44 | 14.83 | 0.87 |
Group 2 A/J rapa daily × 4 weeks | 18.08 | 58.67 | 22.64 | 0.91 |
Group 3 A/J rapa weekly × 12 weeks | 20.88 | 65.86 | 13.02 | 0.25 |